ADARx Pharmaceuticals (ADRX) Stock Price, News & Analysis
Why is ADRX Stock Up Today?
AI-generated explanation by Rhea-AI, written on at . How Rhea-AI works. Not financial advice.
What Changed
Price Move History
- Daily moves over 5%
- 5 31 sessions, September 25, 2026 to November 6, 2026
- Largest daily move
- -11.2% close of November 5, 2026
- 1-month change
- -28.8% closing prices, October 6, 2026 to November 6, 2026
Company Description
ADARx Pharmaceuticals (NASDAQ: ADRX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $1.5B.
ADRX has declined 28.8% over the past month. The last closing price was $13.23.
This page collects what Stock Titan holds for ADRX, including price data, latest news, SEC filings, insider trading activity, upcoming events, and short interest trends.
Stock Performance
ADARx Pharmaceuticals (ADRX) closed at $13.23 on November 6, 2026. Over the past month, the price has lost 28.8%.
ADRX Metrics & Rankings
Price returns through November 6, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
ADARx Pharmaceuticals has 3 recent news articles, with the latest published today. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include IPO, offering. View all ADRX news →
SEC Filings
ADARx Pharmaceuticals has filed 10 recent SEC filings, including 6 Form 4, 2 Form SCHEDULE 13G, 2 Form SCHEDULE 13D. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ADRX SEC filings →
Insider Radar
Insider buying activity at ADARx Pharmaceuticals over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Upcoming Events
UBS fireside chat
ADARx Pharmaceuticals has 1 upcoming scheduled event. The next event, "UBS fireside chat", is scheduled for November 16, 2026 (in 7 days). Investors can track these dates to stay informed about potential catalysts that may affect the ADRX stock price.
Short Interest History
Short interest in ADARx Pharmaceuticals (ADRX) currently stands at 1.9 million shares, up 63.6% from the previous reporting period, representing 2.9% of the float. Since September 2026, short interest has increased by 63.6%.
Days to Cover History
Days to cover for ADARx Pharmaceuticals (ADRX) currently stands at 3.1 days, up 78.7% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since September 2026, the figure has increased by 78.7%. Across the settlements charted above, it has ranged from 1.7 to 3.1 days.
ADRX Company Profile & Sector Positioning
ADARx Pharmaceuticals (ADRX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing ADRX often look at related companies in the same sector, including Nuvation Bio Inc. (NUVB), Damora Therapeutics, Inc. (DMRA), Tyra Biosciences, Inc. (TYRA), Kardigan, Inc. (KARD), and Structure Therapeutics Inc. (GPCR). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ADRX's relative position within its industry.
ADARx Pharmaceuticals (ADRX) announced it will participate in a UBS Global Biopharma Conference fireside chat onNovember 16 ; the announcement describes a scheduled investor presentation, not a clinical or financial update.